Information Provided By: 
Fly News Breaks for May 18, 2017
GMED
May 18, 2017 | 08:52 EDT
Leerink analyst Richard Newitter calls the FDA delaying approval of Globus Medical's ExcelsiusGPS robotic guidance system a "minor setback." The analyst views the issue as timing more than anything else and continues to have confidence in the company's organic revenue growth acceleration prospects. He recommends buying Globus shares on weakness and reiterates an Outperform rating on the name.
News For GMED From the Last 2 Days
There are no results for your query GMED
